Literature DB >> 10396503

High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators.

R Masiá1, A Pena, J Marrugat, J Sala, J Vila, M Pavesi, M Covas, C Aubó, R Elosua.   

Abstract

STUDY
OBJECTIVE: To establish the prevalence of main cardiovascular risk factors in the province of Gerona, where the incidence of myocardial infarction is known to be low.
DESIGN: This was a cross sectional study of prevalence of cardiovascular risk factors conducted on a large random population sample.
SETTING: The province of Gerona, Spain. PARTICIPANTS: Two thousand four hundred and four eligible inhabitants of Gerona aged between 25 and 74 years were randomly selected for a multi-stage sample stratified by age and sex. The following were standardly measured: lipids (total cholesterol, high density, low density, lipoprotein (a) and triglycerides), fibrinogen, basal glycaemia, arterial pressure, anthropometric variables, smoking, history of angina (Rose questionnaire), and a medical history questionnaire. Population measurements were standardised for the world population of 24 to 74 years of age.
RESULTS: The participation rate was 72.7% (1748). Total mean cholesterol was 5.69 mmol/l in men and 5.61 mmol/l in women and mean high density cholesterol was 1.22 mmol/l and 1.47 mmol/l, respectively. Median lipoprotein (a) was 0.22 g/l. These three lipids increased significantly with age. Mean fibrinogen was 2.92 g/l in men and 3.09 g/l in women, and was higher in smokers. The prevalence of hypertension (systolic arterial tension > or = 140 mm Hg or diastolic > or = 90 mm Hg or drug treatment) was 31.3% in men and 27.7% in women. The proportion of male smokers was 33.8% and female smokers 22.7%. The proportion of female smokers in the 25-34 year age group exceeded that of the remaining age groups for both men and women.
CONCLUSIONS: The prevalence of cardiovascular risk factors in Gerona is relatively high for the low myocardial infarction incidence typical of the area, although similar to that of other Spanish areas. The factors that confer sufficient protection to compensate for the effect of the prevalence of these risk factors remain to be elucidated.

Entities:  

Mesh:

Year:  1998        PMID: 10396503      PMCID: PMC1756647          DOI: 10.1136/jech.52.11.707

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  20 in total

1.  [Age-period-cohort analysis of mortality caused by ischemic cardiopathy in Spain 1965-1985].

Authors:  J R Banegas; J C Alberdi; F Rodríguez-Artalejo; V Domínguez; J del Rey Calero
Journal:  Gac Sanit       Date:  1992 May-Jun       Impact factor: 2.139

2.  A questionnaire for the assessment of leisure time physical activities.

Authors:  H L Taylor; D R Jacobs; B Schucker; J Knudsen; A S Leon; G Debacker
Journal:  J Chronic Dis       Date:  1978

3.  Prevalence and correlates of angina pectoris in the Italian nine communities study. Research Group ATS-RF2 of the Italian National Research Council.

Authors:  V Krogh; M Trevisan; S Panico; E Farinaro; M Mancini; A Menotti; G Ricci
Journal:  Epidemiology       Date:  1991-01       Impact factor: 4.822

4.  Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.

Authors:  M F Muldoon; S B Manuck; K A Matthews
Journal:  BMJ       Date:  1990-08-11

5.  The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience.

Authors:  A Reunanen; A Aromaa; K Pyörälä; S Punsar; J Maatela; P Knekt
Journal:  Acta Med Scand Suppl       Date:  1983

6.  Wine, alcohol, platelets, and the French paradox for coronary heart disease.

Authors:  S Renaud; M de Lorgeril
Journal:  Lancet       Date:  1992-06-20       Impact factor: 79.321

7.  Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.

Authors:  J L Jenner; J M Ordovas; S Lamon-Fava; M M Schaefer; P W Wilson; W P Castelli; E J Schaefer
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

8.  Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population.

Authors:  D J Lerner; W B Kannel
Journal:  Am Heart J       Date:  1986-02       Impact factor: 4.749

9.  [Prevalence of ischemic cardiopathy risk factors on the island of Lanzarote].

Authors:  J C Rodríguez Pérez; S Calonge Ramírez; G Bichara Antanios
Journal:  Med Clin (Barc)       Date:  1993-06-05       Impact factor: 1.725

10.  Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik Study.

Authors:  E Sigurdsson; G Thorgeirsson; H Sigvaldason; N Sigfusson
Journal:  Eur Heart J       Date:  1993-05       Impact factor: 29.983

View more
  30 in total

1.  Why mortality from heart disease is low in France. Rates of coronary events are similar in France and Southern Europe.

Authors:  P Ducimetière; T Lang; P Amouyel; D Arveiler; J Ferrières
Journal:  BMJ       Date:  2000-01-22

Review 2.  The French paradox: lessons for other countries.

Authors:  Jean Ferrières
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

3.  [Randomised clinical trial of an intensive intervention into life-styles of patients with hyperfibrinogenaemia in primary prevention of cardiovascular pathology in primary health care].

Authors:  J J Rodríguez Cristóbal; F Benavides Márquez; C Villaverde Grote; E Peña Sendra; F Flor Serra; P Travé Mercadé
Journal:  Aten Primaria       Date:  2005-03-31       Impact factor: 1.137

4.  Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension.

Authors:  Miguel Del Campo; Anna Antonell; Luis F Magano; Francisco J Muñoz; Raquel Flores; Mònica Bayés; Luis A Pérez Jurado
Journal:  Am J Hum Genet       Date:  2006-01-31       Impact factor: 11.025

5.  The peripheral arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population.

Authors:  María Teresa Alzamora; Rosa Forés; José Miguel Baena-Díez; Guillem Pera; Pere Toran; Marta Sorribes; Marisa Vicheto; María Dolores Reina; Amparo Sancho; Carlos Albaladejo; Judith Llussà
Journal:  BMC Public Health       Date:  2010-01-27       Impact factor: 3.295

6.  Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: a population-based cohort study in southern Europe.

Authors:  J Francisco Cano; Jose M Baena-Diez; Josep Franch; Joan Vila; Susana Tello; Joan Sala; Roberto Elosua; Jaume Marrugat
Journal:  Diabetes Care       Date:  2010-06-08       Impact factor: 19.112

7.  An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas.

Authors:  J Marrugat; R D'Agostino; L Sullivan; R Elosua; P Wilson; J Ordovas; P Solanas; F Cordón; R Ramos; J Sala; R Masiá; W B Kannel
Journal:  J Epidemiol Community Health       Date:  2003-08       Impact factor: 3.710

8.  Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, Spain.

Authors:  Eladio Fernández-Liz; Pilar Modamio; Arantxa Catalán; Cecilia F Lastra; Teresa Rodríguez; Eduardo L Mariño
Journal:  Br J Clin Pharmacol       Date:  2007-10-08       Impact factor: 4.335

9.  Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension.

Authors:  José M Fernández-Fernández; Marta Tomás; Esther Vázquez; Patricio Orio; Ramón Latorre; Mariano Sentí; Jaume Marrugat; Miguel A Valverde
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

10.  Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes.

Authors:  Naiara Calvo; Lluís Mont; David Tamborero; Antonio Berruezo; Graziana Viola; Eduard Guasch; Mercè Nadal; David Andreu; Barbara Vidal; Marta Sitges; Josep Brugada
Journal:  Europace       Date:  2010-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.